Purchase Order 36C24726P0150
- Not listed
- Roche Diagnostics Corporation has been awarded a $441,795.47 firm fixed-price purchase order by Veterans Integrated Service Network 5 (VISN 5) for immunohistochemical and special stain instrumentation, with performance at a facility in Castleton, Indiana. The contract, awarded September 26, 2025, with an ultimate completion date of September 25, 2030, fulfills a solicitation originally issued by the Department of Veterans Affairs for fully automated immunohistochemical and special staining...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, to provide histology staining systems. The $348,726.40 contract has a completion date of April 30, 2022 and was awarded on May 1, 2020 with no set-aside designation. Roche Diagnostics has extensive experience as a prime and subcontractor providing critical care analyzers, reagents,...
- This federal contract award is for a TISSUE STAINING ANALYZER, with a ceiling value of $466,070.43, awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract is a Firm Fixed Price Purchase Order with an ultimate completion date of December 14, 2025. The contract was awarded on June 15, 2020 by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 7. Roche Diagnostics has...
- This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite...
- Roche Diagnostics Corporation, a leading provider of in vitro diagnostic solutions, has been awarded a $485,795.68 Delivery Order contract for a six-month histology staining bridge service from April 1, 2025, through March 31, 2026. The contract is being funded through Veterans Integrated Service Network 8 (VISN 8) under a parent General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, and Tests (FSS-65-VII). This award reflects Roche's established role as a critical...
- Roche Diagnostics Corporation was awarded a delivery order valued at $233,538.45 by Veterans Integrated Service Network 6, a component of the Department of Veterans Affairs, for Roche slide preparation and staining services. The contract, which is firm fixed price with no set-aside designation, was awarded on October 1, 2024, with a completion date of September 30, 2025. Work will be performed in Castleton, Indiana. This delivery order represents a child contract under a larger indefinite...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Roche Diagnostics Corporation valued at $599,591.55 for Roche Ventana reagents and consumables during the ordering period ending January 31, 2027. This firm fixed price contract, awarded on February 1, 2026, with no set-aside designation, represents a child award under a larger contract vehicle and will be performed in San Antonio, Texas. Roche Diagnostics Corporation, a foreign-owned...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for a BENCHMARK SPECIAL STAINS FULL SYSTEM with a potential value of $155,000.00. The contract, which does not have a set-aside designation, is funded through the VA's Veterans Integrated Service Network 16 and was awarded on July 22, 2021 with a completion date of September 30, 2021. Roche Diagnostics provides...
- This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Network Contracting Office 6 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $1,388,919.42 contract, which does not have a set-aside designation, is for the provision of H&E and special stainers, reagents, supplies, maintenance, service, and training for routine histologic slide preparation...
- The U.S. Department of Veterans Affairs (VA) awarded a $276,064.00 Firm Fixed Price Delivery Order to Roche Diagnostics Corporation under the General Services Administration (GSA) Scientific Equipment and Services Schedule contract. The contract is for an Automated Immunohistochemical & In Situ Hybridization Stainer to support the VA's Legacy Histobiology and Microbiology project at the Southeast Louisiana Veterans Health Care System in New Orleans, Louisiana. The award was made on...
The Department of Veterans Affairs' Veterans Integrated Service Network 7 awarded a $795,410.15 firm fixed-price purchase order to Roche Diagnostics Corporation for automated tissue staining analyzers on December 15, 2025, with an ultimate completion date of December 14, 2029. This contract is unset-aside and will be performed in Birmingham, Alabama. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, is a established federal contractor with extensive experience supplying diagnostic technologies across VA and Department of Defense Healthcare Agency networks. The automated tissue staining analyzers procured under this contract will support histopathology operations within the VISN 7 healthcare system, enabling advanced tissue specimen processing and analysis critical to diagnostic capabilities. Roche Diagnostics brings significant relevant experience through existing VA contract vehicles, including a $5.17 million histology consumables contract with VISN 6 and multiple other diagnostic equipment agreements across the federal healthcare enterprise. The firm's proven track record in providing histology services, molecular diagnostics, and laboratory instrumentation positions it to deliver equipment and support that will enhance the VA's pathology laboratory capabilities and support patient care delivery across the veterans healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $191.7k | 11/11/25 |